FDA Proposals Fail to Ensure Independent Drug Safety Assessment

In essence FDA proposals merely change the seating arrangement on the deck of the sinking Titanic. Eli Lilly announced that it intends to seek FDA approval for a long-lasting injectable form of Zyprexa (taken once a month). 

Continue reading →

FDA acknowledges failure to act as defibrillator malfunction increased

FDA acknowledges failure to act as defibrillator malfunction increased: 4,225 failed between 2000–2003 Sat, 17 Sep 2005 The Washington Post reports that the number of failed heart defibrillators is increasing: “William H. Maisel, the Harvard Medical School physician who conducted the FDA . . . Continue reading →

TIME inquiry finds top officials at vital gov agencies lack credentials for the job

TIME inquiry finds top officials at vital gov agencies lack credentials for the job Date: Wed, 28 Sep 2005 The New York Times reports today that the mystery of Lester Crawford’s abrupt resignation as head of the FDA “fueled speculation that he . . . Continue reading →

At FDA, Changes In Name Only–Agency Puts Business interests Above Safety

At FDA, Changes In Name Only–Agency Puts Business interests Above Safety Fri, 30 Sep 2005 The sudden resignation of FDA Commissioner, Lester Crawford, after just two months in office, has prompted a bipartisan Senate investigation and requests both by the Senate committee . . . Continue reading →

Drugmakers Go Furthest to Sway Congress: 1,274 Lobbyists – USA Today

Drugmakers Go Furthest to Sway Congress: 1,274 Lobbyists – USA Today Tue, 26 Apr 2005 USA Today provides a glimpse into the way the pharmaceutical industry controls health care policy by buying influence at the highest level of government, and underwriting professional . . . Continue reading →

FDA poised to change the health & wellbeing of all Americans

An illuminating essay by Byron Richards, author of Fight for Your Health: Exposing the FDA’s Betrayal of America,  should be required reading for every member of Congress before voting Yes or NO on the appointment of Dr. Andrew von Eschenbach, who is poised to head the FDA.

Continue reading →